Treatment with the chimeric anti-IL-2Rα basiliximab affects both the IL-2 and IL-15 signalling pathways after clinical kidney transplantation

被引:6
作者
Boelaars-van Haperen, MJAM
Baan, CC
van Riemsdijk, IC
IJzermans, JNM
Weimar, W
机构
[1] Univ Hosp Dijkzigt, Dept Internal Med, NL-3015 GD Rotterdam, Netherlands
[2] Univ Hosp Dijkzigt, Dept Surg, NL-3015 GD Rotterdam, Netherlands
关键词
D O I
10.1016/S0041-1345(00)02306-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1007 / 1008
页数:2
相关论文
共 7 条
[1]   Functional responses of T cells blocked by anti-CD25 antibody therapy during cardiac rejection [J].
Baan, CC ;
van Gelder, T ;
Balk, AHMM ;
Knoop, CJ ;
Holweg, CTJ ;
Maat, LPWM ;
Weimar, W .
TRANSPLANTATION, 2000, 69 (03) :331-336
[2]   A review of interleukin-2 receptor antagonists in solid organ transplantation [J].
Berard, JL ;
Velez, RL ;
Freeman, RB ;
Tsunoda, SM .
PHARMACOTHERAPY, 1999, 19 (10) :1127-1137
[3]   Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody [J].
Kahan, BD ;
Rajagopalan, PR ;
Hall, M .
TRANSPLANTATION, 1999, 67 (02) :276-284
[4]  
Lin Jian-Xin, 1997, Cytokine and Growth Factor Reviews, V8, P313
[5]   Cellular responses to interferons and other cytokines: The JAK-STAT paradigm [J].
Ransohoff, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (09) :616-618
[6]  
Tkaczuk J, 2000, TRANSPLANTATION, V69, pS397
[7]   A multicenter, randomized trial of rapid steroid withdrawal vs. standard steroid treatment in patients treated with Simulect®, Neoral®, and cellcept® for the prevention of acute rejection in renal transplantation. [J].
Vincenti, F ;
Monaco, A ;
Grinyo, J ;
Kinkhabwala, M ;
Neylan, J ;
Roza, A ;
Somberg, K .
TRANSPLANTATION, 1999, 67 (07) :S152-S152